摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-[3-(1,3,4,6,7,8,9,9a-octahydropyrido[1,2-a]pyrazine-2-carbonyl)-2-methoxyanilino]-4-[[(1R)-1-phenylpropyl]amino]cyclobut-3-ene-1,2-dione | 1383453-59-5

中文名称
——
中文别名
——
英文名称
3-[3-(1,3,4,6,7,8,9,9a-octahydropyrido[1,2-a]pyrazine-2-carbonyl)-2-methoxyanilino]-4-[[(1R)-1-phenylpropyl]amino]cyclobut-3-ene-1,2-dione
英文别名
——
3-[3-(1,3,4,6,7,8,9,9a-octahydropyrido[1,2-a]pyrazine-2-carbonyl)-2-methoxyanilino]-4-[[(1R)-1-phenylpropyl]amino]cyclobut-3-ene-1,2-dione化学式
CAS
1383453-59-5
化学式
C29H34N4O4
mdl
——
分子量
502.613
InChiKey
PCGBBOUSDRRVPH-LWMIZPGFSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.1
  • 重原子数:
    37
  • 可旋转键数:
    8
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.41
  • 拓扑面积:
    91
  • 氢给体数:
    2
  • 氢受体数:
    7

文献信息

  • [EN] BICYCLIC RING SYSTEM SUBSTITUTED AMIDE FUNCTIONALISED PHENOLS AS MEDICAMENTS<br/>[FR] PHÉNOLS À FONCTIONNALITÉ AMIDE SUBSTITUÉS PAR UN SYSTÈME CYCLIQUE BICYCLIQUE EN TANT QUE MÉDICAMENTS
    申请人:BOEHRINGER INGELHEIM INT
    公开号:WO2012080456A1
    公开(公告)日:2012-06-21
    This invention relates to bicyclic ring system substituted amide functionalized phenols of general formula 1, their use as inhibitors of CXCR2 activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of respiratory or gastrointestinal complaints or diseases, inflammatory diseases of the joints, skin, or eyes, diseases of the peripheral or central nervous system or cancers, as well as pharmaceutical compositions which contain these compounds.
    这项发明涉及通式1的双环环系统取代酰胺功能化,其用作CXCR2活性抑制剂,含有这些化合物的药物组合物,以及将其用作治疗和/或预防呼吸系统或消化系统疾病、关节、皮肤或眼睛的炎症性疾病、外周或中枢神经系统疾病或癌症的药剂的方法,以及含有这些化合物的药物组合物。
  • BICYCLIC RING SYSTEM SUBSTITUTED AMIDE FUNCTIONALISED PHENOLS AS MEDICAMENTS
    申请人:GIOVANNINI Riccardo
    公开号:US20120329773A1
    公开(公告)日:2012-12-27
    This invention relates to bicyclic ring system substituted amide functionalized phenols of general formula 1, their use as inhibitors of CXCR2 activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of respiratory or gastrointestinal complaints or diseases, inflammatory diseases of the joints, skin, or eyes, diseases of the peripheral or central nervous system or cancers, as well as pharmaceutical compositions which contain these compounds.
    这项发明涉及通式1的双环环系统取代酰胺功能化,其用作CXCR2活性抑制剂,含有相同化合物的药物组合物,以及将其用作治疗和/或预防呼吸道或胃肠道疾病、关节、皮肤或眼睛的炎症性疾病、外周或中枢神经系统疾病或癌症的药剂的方法,以及含有这些化合物的药物组合物。
  • US8648118B2
    申请人:——
    公开号:US8648118B2
    公开(公告)日:2014-02-11
查看更多

同类化合物

麦可弗汀A 罗哌卡因杂质 六氢-2-甲基-2H-吡啶并[1,2-a]吡嗪-1,6-二酮 八氢吡啶并〔1,2-A〕吡嗪-6-酮 八氢吡啶并[1,2-a]吡嗪 八氢-吡啶并[1,2-A]吡嗪-4-酮盐酸盐 八氢-6H-吡啶并[1,2-a]吡嗪-6-酮盐酸盐 八氢-3-甲基-2H-吡啶并[1,2-a]吡嗪 八氢-2H-吡啶并[1,2-a]吡嗪二盐酸盐 八氢-2H-吡啶并[1,2-a]吡嗪-6-甲醇 7-甲氧基辛a氢-2H-吡啶并[1,2-a]吡嗪-2-胺 7-乙基八氢-2H-吡啶并[1,2-a]吡嗪-2-胺 6-甲基八氢-2H-吡啶并[1,2-a]吡嗪-2-胺 4H-吡唑[1,2-A]吡嗪-4-八氢酮 3-甲基八氢-2H-吡啶并[1,2-a]吡嗪-2-胺 2-苄基八氢-1H-吡啶并[1,2-a]吡嗪 2-硝基八氢-2H-吡啶并[1,2-a]吡嗪 2-乙基六氢-2H-吡啶并[1,2-a]吡嗪-1(6H)-酮 2-(9-甲基-3,9-二氮杂双环[3.3.1]壬-3-基)乙胺 2-(4-甲硫基唑-5-基)乙基丁酸酯 2,3,4,6,7,8,9,9alpha-八氢-1H-吡啶并[1,2-a]吡嗪-3-基甲醇 1,1'-联苯基,2-乙基-5-甲氧基- (R)-八氢吡啶并[1,2-A〕吡嗪二盐酸盐 (9aS)-八氢-4H-吡啶并[1,2-a]吡嗪-4-酮 (9aR)-八氢-2H-吡啶并[1,2-a]吡嗪 (9SS)-八氢-2-吡啶-吡嗪盐酸盐[1,2-A] (7r,9as)-八氢-2H-吡啶并[1,2-a]吡嗪-7-甲醇 (3S,6S)-3-苄基-1,4-二氮杂双环[4.4.0]癸烷-2,5-二酮 ((7S,9as)-八氢-1H-吡啶并[1,2-a]吡嗪-7-基)甲醇 ((6R,9as)-八氢-1H-吡啶并[1,2-a]吡嗪-6-基)甲醇 cyclo-(D-Leu-D-Pip) (3S,9aR)-hexahydro-3-methyl-6H-pyrido[1,2-a]pyrazine-1,4-dione (9aS)-2-benzyl-1,3,4,6,7,8,9,9a-octahydropyrido[1,2-a]pyrazine 3-[3-(1,3,4,6,7,8,9,9a-Octahydropyrido[1,2-a]pyrazine-2-carbonyl)-2-methoxyanilino]-4-(2-chloro-3-fluoroanilino)cyclobut-3-ene-1,2-dione (7R,9aS)-trans-7-(3-morpholin-4-ylmethylphenoxymethyl)-octahydro-pyrido[1,2-a]pyrazine-2-carboxylic acid tert-butyl ester 3-[3-(1,3,4,6,7,8,9,9a-octahydropyrido[1,2-a]pyrazine-2-carbonyl)-2-methoxyanilino]-4-[[(1R)-1-phenylpropyl]amino]cyclobut-3-ene-1,2-dione 3-Chinolizidin-1-yl-2-methylindol 2-propyl-octahydro-pyrido[1,2-c][1,3,6]oxadiazocine (8R,9aS)-2-benzyl-3,3-dioxido-1-oxooctahydropyrrolo[2,1-d][1,2,5]thiadiazepin-8-yl cyclohexylcarbamate 2-(5-Amino-2-methoxy-phenyl)-hexahydro-pyrido[1,2-a]pyrazin-3-one 14α-hydroxy-15α-methyl-16β-methylsulfinyl-17-oxomarcfortine A (1S,7S,10S)-12-Acetyl-9-thia-3,12-diaza-tricyclo[8.2.1.03,7]tridecan-2-one (4-Aminophenyl)-(1,3,4,6,7,8,9,9a-octahydropyrido[1,2-a]pyrazin-2-yl)methanone 3-Benzylaminomethyl-chinolizidin rac-(4aR,8aR)-1-(piperidin-3-yl)-decahydroquinoline (1S,7R,10S)-12-Acetyl-9-thia-3,12-diaza-tricyclo[8.2.1.03,7]tridecan-2-one N-((1R,2S,5R)-2-((S)-3-amino-2-oxopyrrolidin-1-yl)-5-(isopropylamino)cyclohexyl)acetamide 2-tert-butylperhydroimidazolo<3,4-a>pyridine 1,3,4,6,7,8,9,9a-Octahydropyrido[1,2-a]pyrazin-2-yl-(2-chloro-5-phenylthiophen-3-yl)methanone 3-[2-oxo-2-[5-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-5,9-diazaspiro[2.6]nonan-9-yl]ethyl]thiazolidine-2,4-dione